Bromodomain and extra-terminal (BET) inhibitors suppress super-enhancers and show cytotoxicity against multiple types of tumors. However, early clinical trials with BET inhibitors showed severe hematopoietic toxicities, highlighting the need for sensitive tumors and rational combination strategies to enhance their therapeutic potential. Here, we identified colon cancer-specific super-enhancers that were associated with multiple oncogenic pathways, including the mitogen-activated protein kinase (MAPK) signaling pathway.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2rCNkph
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
International Journal of Engineering Research and Applications (IJERA) is an open access online peer reviewed international journal that pub...
-
You could soon get an even more immersive VR experience thanks to the Ambiotherm plug in, which exposes you to the elements of your virtual...
-
Abstract T cell immunoglobulin and mucin domain 3 (Tim-3) is a critical regulatory molecule found on activated Th1 cells, exhausted CD8 + ...
-
Join in on the conversation about GCSE Statistics Coursework Help on the TSR community forums. from #AlexandrosSfakianakis via Alexandros ...
-
CFS, also known as ME, may be caused by the body switching from fully breaking down carbohydrates to using other energy sources, bringing o...
-
Study of Sharp Corner Cutting In Wire EDM Thesis submitted in accordance with The test specimens have been cut by using different wire-cut E...
-
Visit this site dedicated to Valentine from 100 Valentine Poems for your special person. Famous Valentine Poems from the Worlds greatest Poe...
-
Planta Med DOI: 10.1055/s-0043-106050 Glucose homeostasis is maintained by antagonistic hormones such as insulin and glucagon as well as ...
-
powerpoint backgrounds, templates, graphics and designs, professional design templates for microsoft powerpoint, free powerpoint backgrounds...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου